Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Yongkai Qin"'
Autor:
Yi Liu, Sindhu Yalavarthi, Fan Yang, Yusif Abdul-Rashid, Shenkun Tang, Zihe Long, Yongkai Qin, Kerui Wu, Zhifei Wang
Publikováno v:
BMC Pulmonary Medicine, Vol 24, Iss 1, Pp 1-16 (2024)
Abstract Background Treatment of non-small lung cancer (NSCLC) has evolved in recent years, benefiting from advances in immunotherapy and targeted therapy. However, limited biomarkers exist to assist clinicians and patients in selecting the most effe
Externí odkaz:
https://doaj.org/article/f63cef02e1224f5c9e56582a00f53780
Publikováno v:
Pharmacological Research, Vol 206, Iss , Pp 107266- (2024)
Cerebral ischemia-reperfusion injury (I/RI) is one of the principal pathogenic factors in the poor prognosis of ischemic stroke, for which current therapeutic options to enhance neurological recovery are notably insufficient. Dental pulp stem cell-de
Externí odkaz:
https://doaj.org/article/31f76d9be90d40aea33c4ed68f1e5f57
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2023)
BackgroundInflammation plays an essential role in the pathogenesis of hypertension. A novel inflammatory biomarker systemic inflammatory response index (SIRI) is related with all-cause and cardiovascular (CVD) mortality, while the role of SIRI in hyp
Externí odkaz:
https://doaj.org/article/6243ff49c25646868b85bd4176f57d22
Autor:
Aihua Liu, Xin Tong, Jigang Chen, Mingyang Han, Linjin Ji, Songfeng Zhao, Yongkai Qin, Lang Liu
Publikováno v:
BMJ Open, Vol 12, Iss 4 (2022)
Objective Recently, a randomised controlled trial (DIRECT-MT) demonstrated that mechanical thrombectomy (MT) was non-inferior to MT with intravenous alteplase as to the functional outcomes. This study aims to investigate whether MT alone is cost-effe
Externí odkaz:
https://doaj.org/article/2ec60ba13156493fb42ae9c29b8f9acc
Autor:
Jigang Chen, Linjin Ji, Xin Tong, Mingyang Han, Songfeng Zhao, Yongkai Qin, Zilong He, Zhiqun Jiang, Aihua Liu
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Background: Although ticagrelor plus aspirin is more effective than aspirin alone in preventing the 30-day risk of a composite of stroke or death in patients with an acute mild-to-moderate ischemic stroke (IS) or transient ischemic attack (TIA), the
Externí odkaz:
https://doaj.org/article/8f4a8d08c2a9465d97ba279dbf02c422
Autor:
Jigang Chen, Xin Tong, Mingyang Han, Songfeng Zhao, Linjin Ji, Yongkai Qin, Zilong He, Yuesong Pan, Chunhui Wang, Aihua Liu
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Background: Glioblastoma multiforme (GBM) is a fatal type of brain tumor with a high incidence among elderly people. Temozolomide (TMZ) has proven to be an effective chemotherapeutic agent with significant survival benefits. This study aimed to evalu
Externí odkaz:
https://doaj.org/article/0e46491587e54cd2a7818b5b02965147
Autor:
Baorui, Zhang, Siyuan, Dong, Yan, Miao, Guangrong, Song, Fei, Yuan, Lang, Liu, Saide, Xia, Yongkai, Qin, Xiaochuan, Huo, Zhongxue, Wu, Zhongrong, Miao, Dapeng, Mo, Aihua, Liu
Publikováno v:
European Journal of Neurology. 29:2967-2975
We used two-sample Mendelian randomization (MR) to examine the effects of blood lipids and lipid-modifying drugs on intracranial aneurysm (IA).Genetic variants for the effects of high-density lipoprotein cholesterol (HDL-C), apolipoprotein A1, low-de
Autor:
Baorui Zhang, Yongkai Qin, Shangfeng Zhao, Wei Wang, Lang Liu, Siyuan Dong, Yan Miao, Songfeng Zhao, Zhongxue Wu, Jun Kang, Aihua Liu
Publikováno v:
Journal of Stroke and Cerebrovascular Diseases. 32:107052
Autor:
Mingyang Han, Yongkai Qin, Xin Tong, Linjin Ji, Songfeng Zhao, Lang Liu, Jigang Chen, Aihua Liu
Publikováno v:
BMJ open. 12(4)
ObjectiveRecently, a randomised controlled trial (DIRECT-MT) demonstrated that mechanical thrombectomy (MT) was non-inferior to MT with intravenous alteplase as to the functional outcomes. This study aims to investigate whether MT alone is cost-effec
Autor:
Jigang Chen, Linjin Ji, Xin Tong, Mingyang Han, Songfeng Zhao, Yongkai Qin, Zilong He, Zhiqun Jiang, Aihua Liu
Publikováno v:
Frontiers in pharmacology. 13
Background: Although ticagrelor plus aspirin is more effective than aspirin alone in preventing the 30-day risk of a composite of stroke or death in patients with an acute mild-to-moderate ischemic stroke (IS) or transient ischemic attack (TIA), the